Andere Sprachen TELA Bio, Inc.

Aktien

A2PUP9

US8723811084

TELA

Realtime-Estimate Cboe BZX Andere Börsenplätze 16:20:07 03.05.2024			% 5 Tage	% 1. Jan.
4,735 ^USD	+2,27 %		+7,30 %	-27,87 %

15.04.	TELA Bio, Inc. kündigt die Markteinführung der roboterkompatiblen OviTex IHR in den USA an	CI
22.03.	TELA BIO, INC. : Piper Sandler bekräftigt seine Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Morgans rates ARX as Add	01.05.
TELA Bio to Announce First Quarter 2024 Financial Results	25.04.
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR, Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	16.04.
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	15.04.
TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR	15.04.
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy	08.04.
Earnings Flash (TELA) TELA BIO Reports Q4 Revenue $17M, vs. Street Est of $16.4M	21.03.
TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21.03.
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results	21.03.
TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2024	21.03.
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery	21.03.
TELA Bio, Inc. Announces U.S. Commercial Launch of LIQUIFIX	21.03.
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	20.03.
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	20.03.
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX	20.03.
MiMedx Group, Inc. Enters into an Agreement with Tela Bio, Inc. to Obtain Exclusive Rights to Its Manufacturing and Supply Agreement	20.03.
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	29.02.
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	29.02.
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23.02.
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen TELA Bio, Inc.

Aktien

A2PUP9

US8723811084

TELA

Andere Sprachen

Filter